Fundraising FoxAkiram Therapeutics
1 known investors
Find your way into Akiram Therapeutics
Sign up to see every warm intro you have to Akiram Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Akiram Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Akiram Therapeutics develops targeted radioimmunotherapy and radiopharmaceuticals to diagnose and treat solid tumors, aiming to deliver radioactivity to cancer cells while sparing healthy tissue. The company, with origins in Uppsala University research, is at a preclinical/clinical development stage in oncology.
Investors · 1
Frequently asked questions
- What does Akiram Therapeutics do?
- Akiram Therapeutics develops targeted radioimmunotherapy and radiopharmaceuticals to diagnose and treat solid tumors, aiming to deliver radioactivity to cancer cells while sparing healthy tissue. The company, with origins in Uppsala University research, is at a preclinical/clinical development stage in oncology.
- Who are Akiram Therapeutics's investors?
- Akiram Therapeutics's investors include Sciety.